Kaohsiung, Taiwan

Wen-Chi Wei

This inventor holds 1 USPTO granted patent. Top assignee: National Sun Yat-Sen University of Kaohsiung. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wen-Chi Wei. Retrieved from https://idiyas.com/inventor/wen-chi-wei-ct65ptax

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Inventor Wen-Chi Wei

Introduction

Wen-Chi Wei is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly through his research on diterpenes derived from corals. His work focuses on addressing diseases associated with various inflammatory markers.

Latest Patents

Wen-Chi Wei holds a patent titled "Pharmaceutical uses of diterpene excavatolide B from a coral or an analogue thereof." This invention pertains to the use of excavatolide B, a diterpene from coral, for treating diseases linked to inducible nitric oxide synthase, cyclooxygenase-2, and matrix metalloproteinase. Additionally, it addresses conditions associated with the over-expression of TNF-α and IL-6. He has 1 patent to his name.

Career Highlights

Wen-Chi Wei is affiliated with the National Sun Yat-sen University of Kaohsiung, where he engages in research and development in the pharmaceutical sciences. His academic background and research initiatives have positioned him as a key figure in his field.

Collaborations

Wen-Chi Wei has collaborated with notable colleagues, including Jyh-Horng Sheu and Ning-Sun Yang, who contribute to his research endeavors. Their combined expertise enhances the impact of their work in the pharmaceutical domain.

Conclusion

Wen-Chi Wei's innovative research and patent contributions reflect his commitment to advancing pharmaceutical applications. His work continues to pave the way for new treatments targeting significant health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…